Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Stryker Corporation (NYSE: SYK) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Stryker Corporation (NYSE: SYK)  concerning whether a series of statements by Stryker Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On August 23, 2017, Stryker Corporation revealed that it informed the U.S. Food and Drug Administration that it was voluntarily recalling certain lots of the Company’s Oral Care products sold through the company’s Sage Products business unit. Additionally, the Company stated that the recalled products were distributed between July 2015 and August 2017, and that the recall is being initiated due to potential cross-contamination involving non-pharmaceutical products.

Following this news, NYSE: SYK fell $7.15 per share, or 4.9%, to close at $138.36 per share on August 23, 2017.

Based in Kalamazoo, Michigan, and founded in 1941 Stryker Corporation operates as a medical technology company. It operates through three segments: Orthopedics; MedSurg; and Neurotechnology and Spine.

If you purchased shares of Stryker Corporation (NYSE: SYK) on or before August 23, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185